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Abstract
Background and Objectives: Poor adherence to medications is one of the major public health challenges. Only one-third of
the population reported successful control of blood pressure, mostly caused by poor drug adherence. However, there are
relatively few reports studying the adherence levels and their associated factors among Chinese patients. This study aimed
to study the adherence profiles and the factors associated with antihypertensive drug adherence among Chinese patients.
Methods: A cross-sectional study was conducted in an outpatient clinic located in the New Territories Region of Hong Kong.
Adult patients who were currently taking at least one antihypertensive drug were invited to complete a self-administered
questionnaire, consisting of basic socio-demographic profile, self-perceived health status, and self-reported medication
adherence. The outcome measure was the Morisky Medication Adherence Scale (MMAS-8). Good adherence was defined as
MMAS scores greater than 6 points (out of a total score of 8 points).
Results: From 1114 patients, 725 (65.1%) had good adherence to antihypertensive agents. Binary logistic regression analysis
was conducted. Younger age, shorter duration of antihypertensive agents used, job status being employed, and poor or
very poor self-perceived health status were negatively associated with drug adherence.
Conclusion: This study reported a high proportion of poor medication adherence among hypertensive subjects. Patients
with factors associated with poor adherence should be more closely monitored to optimize their drug taking behavior.
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Introduction
Poor adherence to medications is a major public health
challenge. Adherence to medication has been defined as the
extent to which patients’ behaviors coincide with health care
providers’ recommendations for health and medical advice [1]. It
can be defined as the extent to which a patient’s behavior, with
respect to taking medication, corresponds with agreed recommen-
dations from a healthcare provider [2]. Hypertension is one of the
most common non-communicable diseases globally. More than
26% of the adult populations worldwide have been diagnosed as
having hypertension, and the prevalence of hypertension increases
with age [3]. Globally, it is also one of the major causes of
premature death, and 7.1 million of people die from hypertension
related diseases annually and the problem is still growing [4].
Successful control of blood pressure is of paramount importance
in the reduction of morbidity and mortality rates [5], and many
studies have demonstrated the impact of antihypertensive agents
on improving clinical outcomes [6–8]. However, the effectiveness
of antihypertensive agents must be achieved by optimal adherence
to prescribed medications according to healthcare providers’
instructions [9].
Although the control of blood pressure has improved consid-
erably, poor adherence with medication treatment remains a major
problem among hypertensive patients, and has been identified as
one of the main causes of failure in achieving blood pressure
control [10]. Only 29% of hypertensive patients in the United
Stated achieved good control, and even worse rates have been
reported in Canada and European countries [11]. It is estimated
that the overall adherence rates of medications were approxi-
mately 50% [12]. Among hypertensive patients who have poor
blood pressure control; poor drug adherence is one of the causes,
and accounts for increasingly significant and substantial public
health burden. Of all avoidable hospital admissions in the United
States, 33 to 69 percent are due to poor medication adherence,
with expenses of approximately $100 billion a year [13,14]. Poor
adherence has been attributed to unnecessary over-prescription of
drugs, substantial worsening of diseases, avoidable increases in
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hospital admission rates, longer hospital stays, leading to
a significant medical burden [15,16]. It is a crucial public health
agenda to improve adherence with antihypertensive medications
by improvements of medication-taking behavior.
Barriers to drug adherence consist of multiple factors that
include complex medication regimens, dosing frequency, behav-
ioral factors and side effects of treatment [16]. The most typical
barriers to drug adherence are under the patient’s control,
including patient’s knowledge and attitudes towards medications.
Therefore, attention to these barriers is a necessary and important
step to improve adherence [16]. Various methods have been
developed to measure medication adherence, and they can be
grouped into three categories: subjective (self-report), direct (serum
or urine drug-level), and indirect (pharmacy database records,
pharmacy refill rates, or pill counts) [10,17]. Each method has its
strengths and drawbacks; and subjective and indirect methods are
more frequently used in adherence-related studies. Self-reported
measures are a relatively simple and inexpensive method, and it
could also include information on social, situational and behav-
ioral factors that affect adherence [10,17].
Antihypertensive drug adherence has been extensively evaluat-
ed in many developed countries in the West using different
methods of medication adherence measurement [18–20]; however
there is a scarcity of studies evaluating the adherence levels of
antihypertensive pharmacotherapies among Chinese population.
This study aims to assess the drug adherence profiles of Chinese
patients prescribed antihypertensive agents, and to examine the
factors associated with antihypertensive drug adherence among
Chinese patients. Self-reported survey as a tool to measure drug
adherence was used in this study to supplement the findings of
previous research reports. As this study evaluated additional
factors including education level, and self-perceived health status
which have not been explored among Chinese patients in previous
studies [21–23], the findings of this study could provide more
comprehensive information for physicians and health care policy
makers with targets to improve medication adherence.
Methods
Ethics Statement
The study was approved by Joint Chinese University of Hong
Kong - New Territories East Cluster Clinical Research Ethics
Committee (CREC) of Hong Kong. The study was conducted
within the researcher’s country of residence. All participants
provided their written informed consent to participate in this
study.
Setting and Subjects
This study was conducted in one of the out-patient clinics in the
New Territories Region from 01 February 2012 to 30 April 2012.
This clinic is a public, primary care clinic run by trained family
physicians. There are around 500 patient visits daily, excluding
evening sessions. All adult patients aged 18 years or older; who are
taking at least one long-term antihypertensive drug; and are able
to communicate and understand Cantonese were invited to
participate. Each potential participant was verbally asked about
the nature of their chronic medication and verified by their hand-
held records to ascertain study eligibility.
Study Design and Protocol
This study is a cross-sectional survey and the data were collected
primarily by self-administered questionnaires. All eligible patients
were invited to complete a self-administered questionnaire
consisting of basic socio-demographic profile, self-perceived health
status, and self-reported medication adherence. University stu-
dents who have attended a standardized workshop on study
protocol and questionnaire administration consecutively screened
for eligible participants and invited them to complete a survey
after obtaining patient consent. For illiterate patients, the student
researchers read the question items word-by-word as exactly
printed on the questionnaire. Each participant had their blood
pressure and body mass index (BMI) measured after survey
completion. The standardized workshops aim to enhance inter-
rater reliability.
Demographic and Clinical Information of the Study
Participants
Participants’ age, gender, level of education, marital status,
number of antihypertensive drug taking, duration of taking
antihypertensive drugs, educational levels, occupation, marital
status and self-perceived health status were obtained through a self-
reported survey. The BMI was measured by a calibrated
stadiometer and weight scale for the study participants on light
clothing without shoes. BMI was further classified by the following
groups: underweight (,18 kg/m2); normal (18–23 kg/m2); over-
weight or obesity (.23 kg/m2). Self-perceived health status
consists of the following categories: excellent and good, not good
and not bad, poor and very poor. It was evaluated by
a questionnaire item designed based on the Health Belief Model
[24] using a 5-point Likert scale.
Assessment of Medication Adherence
Self-reported medication adherence was measured by the eight-
item Morisky Medication Adherence Scale (MMAS-8). The
MMAS-8 has been proven reliable (alpha= 0.83) for assessment
of adherence in patients with hypertension, and is significantly
associated with blood pressure control [25–27]. Using a cut-off of
6, its sensitivity or identifying low vs. higher adherers was
estimated to be 93%. and the specificity was 53% [26]. The
MMAS-8 has been demonstrated to have good concurrent and
predictive validity and might function as a screening tool in
outpatient settings with different patient groups [26]. MMAS-8
scores can range from zero to eight in integers (see Appendix S1).
The precise scoring criteria can be obtained from the developer/
owner. The advantages of this instrument over other methods of
measurement include its simplicity, quick administration and low-
cost. A Chinese version of the MMAS-8 [28] was used and
adapted specifically for antihypertensive agents in this study. The
survey was in Cantonese, tailored-made for use in the Hong Kong
population.
Outcomes Variables and Covariates
The outcome variable in this study is the measure of drug
adherence as assessed by self-reported Morisky scores [26,27,29],
transformed into a dichotomous variable with a score greater than
6 considered as ‘‘good adherence’’. The independent variables
that were controlled for include age, gender, the total number of
antihypertensive drugs used irrespective of medication class,
duration of antihypertensive drug use, educational levels, marital
status, occupation, monthly household income, self-perceived
health status, systolic blood pressure and diastolic blood pressure.
Blood pressure was measured using standardized methodology
based on the 2007 guidelines for the management of arterial
hypertension [30]. All patients had their BP measured twice, each
separated 10 minutes apart. The average of two BP values was
used in the analysis.
Chinese Antihypertensive Medication Adherence
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Statistical Analysis
The PASW Statistics version 18.0 (SPSS) was used for all data
analysis. In the univariate analysis, all variables listed above were
consecutively tested for significant associations with ‘‘good
adherence’’ as the outcome variable. Chi-square tests and
Student’s t-tests were used for categorical and continuous
variables, respectively. All variables were unconditionally entered
into a binary logistic regression model for adjustment. The
absence of multicollinearity was ascertained before the regression
modeling. As part of quality control, each data entered into the
computer were double checked for their accuracy by random
assessment of the survey responses and the data entered. All p
values #0.05 were regarded as statistically significant.
Results
A total of 1,154 consecutive patients completed and returned
the questionnaires. Of those, 24 (2.1%) reported not taking
antihypertensive agents and 7 (0.6%) were missing, and theywere
excluded from the analysis. There were 1,114 completed surveys
included in the analysis. The basic characteristics of these patients
were shown in Table 1. Among the eligible patients, the majority
of patients (60.1%) reported taking one antihypertensive agent and
the mean number of antihypertensive agents used was 1.6 (SD
1.0). The mean year of antihypertensive used was 7.7 years (SD
6.9). The mean systolic blood pressure was 130.6 mmHg (616.9)
and the mean diastolic blood pressure was 74.7 mmHg (69.3).
The mean score of the MMAS-8 was 6.7 (61.4), ranging from 0 to
8. A total of 65.1% of patients obtained a score of greater than 6
and their adherence was categorized as ‘‘good’’, while 32.6% of
patients obtained a score of 6 or below and adherence levels were
classified as ‘‘poor’’.
The characteristics of patients who had good adherence to
antihypertensive agents and patients who had poor adherence
were mostly similar (Table 2). When compared with patients who
had good adherence to antihypertensive agents, more patients who
had poor adherence to antihypertensive agents were younger
(39.2% vs 27.0% were aged ,60), had shorter duration of
antihypertensive agents used (45.2% vs 36.7% were first users of
antihypertensive agents within the past 5 years), more were
employed (31.9% vs 22.2%), and reported a self-perceived health
status of ‘‘poor or very poor’’ (18.9% vs 15.2%).
All variables, which showed significant correlations with the
adherence score, were entered into a multivariate logistic re-
gression model. After adjustment of potential confounders, good
adherence to antihypertensive agents was more common among
those with advanced age, patients who have used antihypertensive
agents for more than ten years, and those who were unemployed
or retired (Table 3). As a sensitivity analysis, unemployed patients
were separated from the retired and the identical logistic
regression model was repeated. The associated factors found were
similar to that in the original regression analysis (data not shown).
In addition, patients who reported a self-perceived health status of
‘‘poor or very poor’’ were more likely to report poor adherence to
antihypertensive agents (Table 3).
Discussion
The purpose of this study was to study the adherence profiles of
Chinese patients prescribed antihypertensive agents and the
factors associated with drug adherence using a self-administered
questionnaire. The overall rate of good adherence to antihyper-
tensive agents (65.1%) was not as high as a previous study among
Chinese population (85.5%) [10], and was slightly lower than the
adherence rate of 71.6% among patients in Urban health Clinic
Setting using the MMAS-8 in the U.S [31]. Other studies in
western population reported rates ranging from 53% to 91%
[32,33]. The rate of adherence may differ by many factors,
including types of population, study design, method of measure-
ment, to quote a few. It has been reported that cultural factors
might influence antihypertensive adherence which could explain
different levels of adherence among different populations. These
include cultural health perception of hypertension, health percep-
tions of Western medications, self-care behavior and social support
[34].
Several studies have also evaluated the factors associated with
antihypertensive drug adherence [35–37]. Age, gender, the
number of antihypertensive agents, and socioeconomic status
were found to be associated with drug adherence. One of the
studies conducted in a Chinese population [38] has found that that
many of the factors associated with antihypertensive drug
adherence among Chinese patients were similar to those identified
by studies conducted in Western populations. Among Chinese
patients, there were previous studies which utilized Medication
Possession Ratio (MPR) as a measure of adherence from
retrospective dataset analysis [30,38–42]. These reports were
different from this study which prospectively evaluated medication
adherence using a self-reported instrument. We are of the view
that both types of studies could be interpreted in different
perspectives to inform the current situation of medication non-
adherence in Chinese patients.
The association between age and drug adherence is complex
and the conclusion is currently mixed in the literature. In this
study, patients with older age were found to be more adherent
than patients with younger age. This finding was compatible with
the majority of studies that advanced age was reported to be
associated with good adherence to antihypertensive agents
[10,17,31,43,44]. A possible explanation is the greater number
of comorbidities among elderly patients, who might perceive
themselves as sicker and hence adhere better to antihypertensive
prescriptions [34]. But conversely, some researchers reported the
opposite correlation where poor adherence was associated with
increasing age [36,45]. Other variables like individual’s cognitive
level, physical mobility, and self-care abilities may affect the
relationship between age and adherence.
In this study, patients with longer duration of antihypertensive
agents used (over 10 years) reported better adherence than patients
with shorter duration (5 years or less). This finding was consistent
with a previous study using the MMAS-8 where poor antihyper-
tensive drug adherence was more commonly found among those
first diagnosed with hypertension for less than 10 years [31]. One
explanation for this could be that patients having longer duration
of taking antihypertensive agents could have gained more
experience with hypertension, established a better physician-
patient relationship and had greater faith on physicians’ advice. In
addition, they might become more knowledgeable about their own
health condition and the appropriate management of disease
control [46].Turning to occupation, patients who were unem-
ployed or retired were more likely to be compliant. Few studies
have reported the relationship between occupation and adherence.
Some studies have shown that unemployed patients tended to have
poorer adherence [47]; and the lack of health care coverage is
a hidden issue that has emerged as important. Health care systems
and practices of different countries may affect the result [48]. It is
possible that the positive association between unemployed or
retired statuses and good adherence to antihypertensive agents was
mediated by having low-cost subsidy, and that medical service was
relatively accessible in Hong Kong.
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In addition, patients who reported a self-perceived health status
of ‘‘poor or very poor’’ were less likely to be adherent to
antihypertensive agents when compared with those who reported
a self-perceived health status of ‘‘excellent or good’’. Patients’
perception and attitudes towards health have been recognized as
one of the barriers to drug adherence [16]. It is therefore possible
that patients reported a self-perceived health status of ‘‘poor or
very poor’’ have a relatively poorer self-control and negative
beliefs about hypertension, limiting their adherence to antihyper-
tensive medication regimes.
To our knowledge, this is the first study that evaluated the
adherence profile of antihypertensive agents among Chinese
patients using the measuring tool of the MMAS-8. Self-reported
survey as a tool to measure drug adherence used in this study
supplemented the findings of previous studies. As additional
factors including education level, and self-perceived health status
where previous studies have not explored in Chinese population
were evaluated in this study, the findings of this study provide clear
implications to physicians and health care policy makers. It is
obvious that patients with the identified associated factors should
receive more intensive monitoring for drug adherence. Effective
strategies to improve drug adherence can be achieved by
reinforcement of regular monitoring of blood pressure at home,
educational programmes involving family member, consultations
Table 1. Patient characteristics.
Total study population (N=1,114)
N %
Gender Male 464 41.7
Female 648 58.3
Age Mean (SD) 65.7 (11.1)
,60 341 31.0
60–65 242 22.0
66–69 110 10.1
$70 406 36.9
No. of antihypertensive drugs used Mean (SD) 1.6 (1.0)
1 662 60.1
2 325 29.5
$3 114 10.4
Duration of antihypertensive drugs used
(year)
Mean (SD) 7.7 (6.9)
,5 years 531 47.9
5–10 years 336 30.3
.10 years 241 21.8
Body Mass Index* Underweight 26 3.2
Normal Weight 210 25.9
Overweight or Obesity 583 70.9
Marital status Married 838 76.1
Single/Divorced/Widowed/Cohabited 263 23.9
Education level Primary or below 597 54.0
Secondary 440 39.8
Tertiary or above 68 6.2
Occupation Employed 282 25.8
Unemployed/Retired 531 48.5
Housewife 281 25.7
Monthly Household income 0–10000 501 57.0
100001–20000 222 25.3
20001–30000 89 10.1
30001+ 67 7.6
Current Health Status Excellent or Good 269 24.5
Not Good and Not Bad 645 58.9
Poor or Very Poor 182 16.6
Systolic blood pressure 1,081 130.6/16.9 (Mean/SD)
Diastolic blood pressure 1,080 74.7/9.3 (Mean/SD)
*Body Mass Index is calculated as weight in kg/(height in meters)2.
doi:10.1371/journal.pone.0062775.t001
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Table 2. Patient characteristics according to antihypertensive drug adherence.
Good adherence Poor adherence p
n % n %
Total Study Population 725 65.1 363 32.6
Age Mean (SD) 718 67.4 (10.9) 355 64.8 (11.2) ,0.001
,60 194 27 139 39.2
60–65 149 20.8 85 23.9
66–69 80 11.1 27 7.6
$70 295 41.4 104 29.3
Gender 723 363 0.073
Male 314 43.3 137 37.7
Female 409 56.4 226 62.3
No. of antihypertensive used 716 1.5 (0.8) 359 1.6 (1.1) 0.813
1 427 59.6 221 61.6
2 215 30 104 29
$3 74 10.3 34 9.5
Duration of antihypertensive used
(year)
722 8.0 (6.8) 361 7.6 (6.9) 0.006
,5 years 265 36.7 163 45.2
5–10 years 283 39.2 137 37.7
.10 years 174 24.1 61 16.8
Body Mass Index (kg/m2)* 526 265 0.989
Underweight 17 3.2 9 3.4
Normal Weight 133 25.3 70 26.4
Overweight or Obesity 376 71.5 186 70.2
Education level 719 360 0.246
Primary or below 402 55.9 183 50.8
Secondary 272 37.8 155 43.1
Tertiary or above 45 6.3 22 6.1
Marital status 716 360 0.961
Married 544 76.0 274 76.1
Single/Divorced/Widowed/
Cohabited
172 24.0 86 23.9
Occupation 715 357 ,0.001
Employed 159 22.2 114 31.9
Unemployed/retired 386 54 137 38.4
Housewife 170 23.8 106 29.7
Monthly Household income ($HK) 571 291 0.472
0–10000 335 58.7 155 53.3
100001–20000 138 24.2 80 27.5
20001–30000 54 9.5 33 11.3
30000+ 44 7.7 23 7.9
Current Health Status 719 355 0.069
Excellent or Good 189 26.3 73 20.6
Not Good and not Bad 421 58.6 215 60.6
Poor or Very Poor 109 15.2 67 18.9
Systolic Blood Pressure Mean (SD) 724 130.8 (16.36) 358 130.5 (17.11) 0.704
Diastolic Blood Pressure Mean (SD) 724 73.5 (9.04) 357 75.3 (9.43) 0.853
*Body Mass Index is calculated as weight in kg/(height in metres)2.
doi:10.1371/journal.pone.0062775.t002
Chinese Antihypertensive Medication Adherence
PLOS ONE | www.plosone.org 5 April 2013 | Volume 8 | Issue 4 | e62775
by community pharmacists, and sending reminders of clinical
appointments and regular drug taking [48].
Several limitations of our study should be addressed here. First,
our sample was taken in a single out-patient clinic in the New
Territories region, and patients’ characteristics may differ from
other districts, hence limiting its representativeness and it may not
be generalizable to other health care settings. Secondly, we have
excluded those hypertensive patients who were unable to
communicate and understand Cantoneseand this could over-
estimate the adherence level by including patients with higher
educational levels than the general public. Also, research
methodologies involving self-reported measures depend largely
on individuals’ memory, and recall bias may exist. In additional,
many other factors such as barriers to medication taking, patients’
knowledge and attitudes towards long-term drug use which could
influence adherence were unable to be controlled. Lastly, the
absence of association between the Morisky scores and the blood
pressure levels is unexpected. One explanation is that we have not
excluded patients having white-coat hypertension despite the
standard methodology to measure BP. Further studies are needed
to evaluate the relationship between this scale and BP levels
among Chinese hypertensive patients.
Conclusions
In conclusion, some factors associated with antihypertensive
drug adherence among Chinese patients using the MMAS-8 were
novel findings as compared with studies conducted in Chinese
patients using Medication possession ratio (MPR) [30,38–42] and
other studies conducted in Western population. Since studies on
drug adherence to antihypertensive agents among Chinese
population is scarce, further investigation is required to evaluate
the applicability of MMAS as a tool of drug adherence
measurement among Chinese patients. The factors identified in
this study denote those individuals at risk for poor antihypertensive
drug adherence, and future research studies should identify the
reasons for their non-adherence. More drug adherence-enhancing
strategies should be focused on these groups of patients, and the
most effective models of which should be evaluated in separate
patient groups.
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